Preferential transmission of minority and drug-resistant clones in polyclonal infections in Mali
Abstract Background In polyclonal human malaria infections, the roles of individual clones in human-to-mosquito transmission and their relative transmissibility remain poorly understood. In addition, mutations conferring drug resistance can result in a transmission advantage or disadvantage. Methods...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Malaria Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12936-025-05298-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850269678525480960 |
|---|---|
| author | Leen N. Vanheer Emilia Manko Almahamoudou Mahamar Jody Phelan Koualy Sanogo Youssouf Sinaba Sidi M. Niambele Adama Sacko Sekouba Keita Ahamadou Youssouf Makonon Diallo Harouna M. Soumare Kjerstin Lanke Djibrilla Issiaka Halimatou Diawara Sekou F. Traore Lynn Grignard Alassane Dicko Chris Drakeley Susana Campino William Stone |
| author_facet | Leen N. Vanheer Emilia Manko Almahamoudou Mahamar Jody Phelan Koualy Sanogo Youssouf Sinaba Sidi M. Niambele Adama Sacko Sekouba Keita Ahamadou Youssouf Makonon Diallo Harouna M. Soumare Kjerstin Lanke Djibrilla Issiaka Halimatou Diawara Sekou F. Traore Lynn Grignard Alassane Dicko Chris Drakeley Susana Campino William Stone |
| author_sort | Leen N. Vanheer |
| collection | DOAJ |
| description | Abstract Background In polyclonal human malaria infections, the roles of individual clones in human-to-mosquito transmission and their relative transmissibility remain poorly understood. In addition, mutations conferring drug resistance can result in a transmission advantage or disadvantage. Methods Amplicon sequencing of complexity of infection and drug resistance markers was used to analyse post-treatment stage-specific malaria parasite dynamics in human blood infections and in the midguts of mosquitoes that became infected after direct membrane feeding assays (DMFAs). Blood samples originated from 50 asymptomatic Plasmodium falciparum gametocyte-carrying participants. These were collected prior to treatment and at five timepoints over 28 days following a three-day artemisinin-based combination therapy (ACT) regimen of dihydroartemisinin-piperaquine or pyronaridine-artesunate at the Ouélessébougou Clinical Research Unit of the Malaria Research and Training Centre of the University of Bamako (Bamako, Mali). At each study visit, DMFAs were conducted. Results A total of 57 Pfcsp haplotypes and 53 Pftrap haplotypes were identified, indicating high genetic diversity among parasite clones. Prior to treatment, human infections were more often polyclonal and had a higher median multiplicity of infection (MOI; 3 (IQR 2–5)), compared to mosquito midgut infections (1 (IQR 1–2)). At this timepoint, it is likely that some clones detected in human blood are not producing gametocytes and are, therefore, not contributing to mosquito transmission. Minority clones preferentially transmitted, and these same clones often persisted in the human blood samples post-treatment. These observations mirror the rapid decline in asexual parasite density that occurs after ACT initiation, and the more persistent circulation of gametocytes. The data, therefore, suggests that asexual gametocyte-non-producing clones outnumber the gametocyte-producing clones at baseline, yet it is these gametocyte-producing minority clones that are transmitted to and surviving in mosquitoes. Certain haplotypes were also found to be more prevalent in human samples compared to mosquito infections, and vice versa, with 12.6% of haplotypes at baseline exclusively observed in mosquitoes. Along with this, varying odds of transmission for different parasite clones were observed, indicating that there are inherent clonal differences in gametocyte productivity or viability. To assess the transmission of drug-resistant clones, the overall prevalence of molecular markers of drug resistance was determined in both human and mosquito hosts, followed by a pairwise comparison between human blood infections and paired infected midguts. This showed that Asn51Ile in Pfdhfr and Lys540Glu in Pfdhps may have a transmission advantage under ACT, while Ala613Ser in Pfdhps may confer a transmission disadvantage. Conclusions Overall, these findings indicate that parasite dynamics and clonal transmissibility are highly complex, even after ACT. This complexity may have important epidemiological implications, as it suggests the transmission of minority clones and highlights the impact of drug resistance markers on transmissibility. |
| format | Article |
| id | doaj-art-d501d38e64234ffdb90a9ebc7c0ab83f |
| institution | OA Journals |
| issn | 1475-2875 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | Malaria Journal |
| spelling | doaj-art-d501d38e64234ffdb90a9ebc7c0ab83f2025-08-20T01:53:00ZengBMCMalaria Journal1475-28752025-04-0124111110.1186/s12936-025-05298-6Preferential transmission of minority and drug-resistant clones in polyclonal infections in MaliLeen N. Vanheer0Emilia Manko1Almahamoudou Mahamar2Jody Phelan3Koualy Sanogo4Youssouf Sinaba5Sidi M. Niambele6Adama Sacko7Sekouba Keita8Ahamadou Youssouf9Makonon Diallo10Harouna M. Soumare11Kjerstin Lanke12Djibrilla Issiaka13Halimatou Diawara14Sekou F. Traore15Lynn Grignard16Alassane Dicko17Chris Drakeley18Susana Campino19William Stone20Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoDepartment of Medical Microbiology and Radboud Center for Infectious Diseases, Radboud University Medical CenterMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineMalaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of BamakoDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical MedicineAbstract Background In polyclonal human malaria infections, the roles of individual clones in human-to-mosquito transmission and their relative transmissibility remain poorly understood. In addition, mutations conferring drug resistance can result in a transmission advantage or disadvantage. Methods Amplicon sequencing of complexity of infection and drug resistance markers was used to analyse post-treatment stage-specific malaria parasite dynamics in human blood infections and in the midguts of mosquitoes that became infected after direct membrane feeding assays (DMFAs). Blood samples originated from 50 asymptomatic Plasmodium falciparum gametocyte-carrying participants. These were collected prior to treatment and at five timepoints over 28 days following a three-day artemisinin-based combination therapy (ACT) regimen of dihydroartemisinin-piperaquine or pyronaridine-artesunate at the Ouélessébougou Clinical Research Unit of the Malaria Research and Training Centre of the University of Bamako (Bamako, Mali). At each study visit, DMFAs were conducted. Results A total of 57 Pfcsp haplotypes and 53 Pftrap haplotypes were identified, indicating high genetic diversity among parasite clones. Prior to treatment, human infections were more often polyclonal and had a higher median multiplicity of infection (MOI; 3 (IQR 2–5)), compared to mosquito midgut infections (1 (IQR 1–2)). At this timepoint, it is likely that some clones detected in human blood are not producing gametocytes and are, therefore, not contributing to mosquito transmission. Minority clones preferentially transmitted, and these same clones often persisted in the human blood samples post-treatment. These observations mirror the rapid decline in asexual parasite density that occurs after ACT initiation, and the more persistent circulation of gametocytes. The data, therefore, suggests that asexual gametocyte-non-producing clones outnumber the gametocyte-producing clones at baseline, yet it is these gametocyte-producing minority clones that are transmitted to and surviving in mosquitoes. Certain haplotypes were also found to be more prevalent in human samples compared to mosquito infections, and vice versa, with 12.6% of haplotypes at baseline exclusively observed in mosquitoes. Along with this, varying odds of transmission for different parasite clones were observed, indicating that there are inherent clonal differences in gametocyte productivity or viability. To assess the transmission of drug-resistant clones, the overall prevalence of molecular markers of drug resistance was determined in both human and mosquito hosts, followed by a pairwise comparison between human blood infections and paired infected midguts. This showed that Asn51Ile in Pfdhfr and Lys540Glu in Pfdhps may have a transmission advantage under ACT, while Ala613Ser in Pfdhps may confer a transmission disadvantage. Conclusions Overall, these findings indicate that parasite dynamics and clonal transmissibility are highly complex, even after ACT. This complexity may have important epidemiological implications, as it suggests the transmission of minority clones and highlights the impact of drug resistance markers on transmissibility.https://doi.org/10.1186/s12936-025-05298-6MalariaPlasmodium falciparumGametocytesTransmissionComparative genomicsGenetic diversity |
| spellingShingle | Leen N. Vanheer Emilia Manko Almahamoudou Mahamar Jody Phelan Koualy Sanogo Youssouf Sinaba Sidi M. Niambele Adama Sacko Sekouba Keita Ahamadou Youssouf Makonon Diallo Harouna M. Soumare Kjerstin Lanke Djibrilla Issiaka Halimatou Diawara Sekou F. Traore Lynn Grignard Alassane Dicko Chris Drakeley Susana Campino William Stone Preferential transmission of minority and drug-resistant clones in polyclonal infections in Mali Malaria Journal Malaria Plasmodium falciparum Gametocytes Transmission Comparative genomics Genetic diversity |
| title | Preferential transmission of minority and drug-resistant clones in polyclonal infections in Mali |
| title_full | Preferential transmission of minority and drug-resistant clones in polyclonal infections in Mali |
| title_fullStr | Preferential transmission of minority and drug-resistant clones in polyclonal infections in Mali |
| title_full_unstemmed | Preferential transmission of minority and drug-resistant clones in polyclonal infections in Mali |
| title_short | Preferential transmission of minority and drug-resistant clones in polyclonal infections in Mali |
| title_sort | preferential transmission of minority and drug resistant clones in polyclonal infections in mali |
| topic | Malaria Plasmodium falciparum Gametocytes Transmission Comparative genomics Genetic diversity |
| url | https://doi.org/10.1186/s12936-025-05298-6 |
| work_keys_str_mv | AT leennvanheer preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT emiliamanko preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT almahamoudoumahamar preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT jodyphelan preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT koualysanogo preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT youssoufsinaba preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT sidimniambele preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT adamasacko preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT sekoubakeita preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT ahamadouyoussouf preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT makonondiallo preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT harounamsoumare preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT kjerstinlanke preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT djibrillaissiaka preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT halimatoudiawara preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT sekouftraore preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT lynngrignard preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT alassanedicko preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT chrisdrakeley preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT susanacampino preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali AT williamstone preferentialtransmissionofminorityanddrugresistantclonesinpolyclonalinfectionsinmali |